日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Osimertinib inhibits the MYLK4-mediated phosphorylation of CDKAL1 to suppress stemness and chemoresistance in rhabdomyosarcoma

奥希替尼通过抑制MYLK4介导的CDKAL1磷酸化来抑制横纹肌肉瘤的干性和化疗耐药性。

Itano, Takuto; Huang, Rongsheng; Ozaki, Toshifumi; Nakata, Eiji; Fujimura, Atsushi

Single-cell protein activity analysis reveals aberrant myogenesis and IGF2-PI3K pathway dependencies in MYOD1-mutant rhabdomyosarcoma.

单细胞蛋白质活性分析揭示了MYOD1突变横纹肌肉瘤中异常的肌生成和IGF2-PI3K通路依赖性。

International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized disease

一项关于多形性横纹肌肉瘤(P-RMS)的国际多中心回顾性研究,一项PUSH平台研究:原发性局限性疾病的预后

Giani, C; Baldi, G G; Ljevar, S; Denu, R A; Andelkovic, V; Han, I; Brunello, A; Napolitano, A; Bhadri, V A; Scanferla, R; Garcia, A S; Abreu, M H; Campos, F; Ogura, K; Wong, D D; Bae, S; Marquina, G; Mazzocca, A; Yang, V; Nakazawa, M S; Kim, H-S; Chiusole, B; Thway, K; Antonescu, C; Bellan, E; Bovée, J V M G; Davis, J L; Dei Tos, A P; Di Blasi, E; Lazar, A J; Sbaraglia, M; Schaefer, I-M; Taverna, S; Chen, T W-W; Miceli, R; Gronchi, A; Stacchiotti, S

CAR-T cell immunotherapy in rhabdomyosarcoma

CAR-T细胞免疫疗法治疗横纹肌肉瘤

Safarzadeh Kozani, Pooria; Dashti Shokoohi, Setareh; Safarzadeh Kozani, Pouya

Therapeutic targeting of YOD1 disrupts the PAX-FOXO1/N-Myc feedback loop in rhabdomyosarcoma.

针对 YOD1 的治疗可以破坏横纹肌肉瘤中的 PAX-FOXO1/N-Myc 反馈回路。

Ying Wenwen, Yu Jiayi, Wang Xiaomin, Liu Jiayi, Deng Boyu, Shao Xuejing, Wang Jinhu, Tao Ting, Cao Ji, He Qiaojun, Yang Bo, Chen Yifan, Ying Meidan

Involvement of the FGF8/FGF Receptor Signaling Pathway in the Maintenance and Progression of Fusion-Positive Rhabdomyosarcoma

FGF8/FGF受体信号通路在融合阳性横纹肌肉瘤的维持和进展中的作用

Boudjadi, Salah; Kim, Hana; Chatterjee, Bishwanath; Raut, Pawan Kumar; Nguyen, Thanh Hung; Pandey, Puspa Raj; Ur Rasool, Reyaz; Sun, Wenyue; Barr, Frederic G

FOXM1 inhibitor, RCM‑1, enhances venetoclax mediated apoptosis through downregulation of ATP2B4 in rhabdomyosarcoma

FOXM1抑制剂RCM-1通过下调横纹肌肉瘤中的ATP2B4来增强维奈托克介导的细胞凋亡

Merjaneh, Nawal; Lan, Ying-Wei; Deng, Zicheng; Donovan, Johnny; Wang, Guolun; Do, Jonathan; Juan, Tiffany; Xia, Xiaomei; Kalinichenko, Vladimir V; Kalin, Tanya V

Gene Amplification in Rhabdomyosarcoma: Lessons from a Rare Cancer

横纹肌肉瘤中的基因扩增:来自一种罕见癌症的启示

Barr, Frederic G

Intratumoral and peritumoral radiomics for the pretreatment prediction of response to neoadjuvant chemotherapy in rhabdomyosarcoma: a multicenter retrospective cohort study

肿瘤内和肿瘤周围放射组学在横纹肌肉瘤新辅助化疗疗效预测中的应用:一项多中心回顾性队列研究

Zhang, Ge; Peng, Yun; Su, Yan; Mei, Lin; Fang, Jugao; Liu, Yuanhu; Wang, Huanming; Song, Hongcheng; Guo, Dong; Yu, Guoxia; Wang, Shengcai; Ni, Xin

The Development of Novel Treatment Strategies for Rhabdomyosarcoma

横纹肌肉瘤新型治疗策略的开发

Nakano, Kenji